153 related articles for article (PubMed ID: 33789153)
1. In vitro and in vivo effects of P-MAPA immunomodulator on schistosomiasis.
Silva JCS; Lins CRB; Lacerda SS; Ramos REM; Araújo HDA; Melo-Junior MR; Alves LC; Brayner FA; Nunes IS; Melo FL; Carvalho BM
Acta Trop; 2021 Jun; 218():105909. PubMed ID: 33789153
[TBL] [Abstract][Full Text] [Related]
2. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
[TBL] [Abstract][Full Text] [Related]
3. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
Allam G; Eweas AF; Abuelsaad AS
Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
[TBL] [Abstract][Full Text] [Related]
4. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
[TBL] [Abstract][Full Text] [Related]
6. Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.
Meister I; Ingram-Sieber K; Cowan N; Todd M; Robertson MN; Meli C; Patra M; Gasser G; Keiser J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5466-72. PubMed ID: 24982093
[TBL] [Abstract][Full Text] [Related]
7. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
8. Use of kinase inhibitors against schistosomes to improve and broaden praziquantel efficacy.
Nawaratna SSK; McManus DP; Gasser RB; Brindley PJ; Boyle GM; Rivera V; Ranasinghe SL; Jones MK; You H; Gobert GN
Parasitology; 2020 Nov; 147(13):1488-1498. PubMed ID: 32741402
[TBL] [Abstract][Full Text] [Related]
9. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
10. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
12. Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo.
Metwally DM; Al-Olayan EM; Alanazi M; Alzahrany SB; Semlali A
BMC Complement Altern Med; 2018 Apr; 18(1):135. PubMed ID: 29703259
[TBL] [Abstract][Full Text] [Related]
13. THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL.
Mendonça AM; Feitosa AP; Veras DL; Matos-Rocha TJ; Cavalcanti MG; Barbosa CC; Brayner FA; Alves LC
Rev Inst Med Trop Sao Paulo; 2016; 58():7. PubMed ID: 26910445
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.
El-Bassiouni EA; Helmy MH; Saad EI; El-Nabi Kamel MA; Abdel-Meguid E; Hussein HS
Br J Biomed Sci; 2007; 64(4):168-74. PubMed ID: 18236739
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
Kovač J; Vargas M; Keiser J
Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
[TBL] [Abstract][Full Text] [Related]
16. The potent effect of silymarin combination with Praziquantel or mirazid for Schistosoma mansoni treatment in infected male swiss albino mice.
El-Nagar DM; Al Olayan EM; Aloufi AS; Khatab AR
Trop Biomed; 2021 Mar; 38(1):22-27. PubMed ID: 33797519
[TBL] [Abstract][Full Text] [Related]
17. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
18. A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Eldeeb E; Fahmy S; Elbakry K; Hyder A
Biomed Pharmacother; 2018 Mar; 99():570-575. PubMed ID: 29902867
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
